Irifrin - dhibcood oo isha

"Irifrin" - indhaha lagu dhibciyo, ay yihiin hufan, midab ama xal huruud ah iftiin. diyaarinta waxa uu leeyahay hawl Alfa-adrenergic fahmayaan. "Irifrin" dhibco lagu shubo indhaha lahayn saamayn dareemi kobcinaya on habka dhexe ee neerfayaasha. dejinta Tan waxaa laga dhayayo codsatay, waxa sababa furanto ee ardayga, dheecaanka ah hagaagay iyo intraocular dheecaan vasoconstriction conjunctiva.

"Irifrin" - tilmaamaha loo isticmaalo

At qalbiga daroogada tani waa phenylephrine, kaas oo u dareen ah receptors Alfa-adrenergic postsynaptic iyo leedahay tallaabo yar on receptors beta-adrenergic waxyaalaha qalbiga ku jira. gulucdooda "Irifrin" saamayn vasoconstrictor taas oo la mid ah tallaabada of norepinephrine. daroogada ka dib dhacaa mydriasis. urureen meesha ugu sarreysa ee phenylephrine 10-20 daqiiqo ka dib dhacdaa unugyada isha

Waxaa lagu talinayaa in la isticmaalo "Irifrin" indhaha lagu dhibciyo in arrimaha soo socda:

- at iridocyclitis, si loo yareeyo deynta maadoyinka gobolka of iris ah, iyo sidoo kale ka hortagga synechiae dambe;

- si ay u fuliyaan ballaarinta ardayga, halkaas oo loo baahan yahay, oo ay cudurka, si ay u awoodaan si ay ula socdaan gobolka of dambe ee isha,

- si loo fuliyo baaritaanka daandaansi ah kuwa bukaanada qaba profile cidhiidhi ah ee xagal qolkii jilibka ama looga shakisan yahay glaucoma xiro;

- for ogaanshaha kala duwan ee la isku duro qoto dheer oo maqaar saar ah ee bu'da isha ;

- si loo ballaariyo ardayga ee tababarka lagu jiro predopretsionnoy;

- inta lagu guda jiro qalliinka vitreoretinal, si ay u kordhiyaan ardayga, iyo marka fulinta hawlgalka la laser ah fundus isha ;

- qabashada adag caafimaad ay goobjoog ka ahaayeen dhibaatooyinka glaucoma-tsikliticheskih;

- inta lagu guda jiro muujinta dabac hoy;

- daweynta ee loo yaqaan syndrome ee "isha cas", iyo isticmaalka daroogada this ka caawisaa yareeyo caro iyo isha xuubka bafinayo.

"Irifrin" dhibco lagu shubo indhaha - sababo

diyaarinta waa in aan loo isticmaalin haddii bukaanku soo socda cudurada:

- joogitaanka of dareen diidmo oo xasaasiyadeed in qaybaha ka mid ahaa in daroogada caafimaad la joogo;

- joogitaanka bukaan-xidho ama glaucoma cidhiidhi-xagal,

- isticmaalka daroogada, laguma talinayo inay dadka waayeelka ah ee rabshooyin daran ee nidaamka wadnaha ama nidaamka cerebrovascular;

- Ma codsan kartid daroogada ee furanto arday oo dheeraad ah inta lagu guda jiro qalliinka ee kuwa bukaanada qaba xadgudub ku ah daacadnimada bu'da ama daciif ah wax soo saarka jeex;

- codsiga of xal 10% ka mid ah ayaa sheegay in samaynta a waa u carruurta ka yar 12 sano kuwaas oo jir leeyihiin aneurysm halbowlaha;

- mamnuucay isticmaalka xal 2.5% dhallaanka risk;

- isticmaalka daroogada waa u in joogitaanka tayroodh, porfyri cagaarshowga, deficiency ee lagu dhasho ee dehydrogenase glucose-6-phosphate.

Iyada oo taxaddar waa in la isticmaalaa siiyey daroogada si uu dadka qaba sonkorowga, dadka waayeelka ah. Ha qaadan "Irifrin" si wadajir ah ula MAO, codsiga sida suurto gal ah ka dib markii marinka of 21 maalmood laga bilaabo taariikhda joojinta ay gelitaanka.

Ha ka badan qiyaasta lagula talinayaa dadka qaba dhaawacyada iyo cudurrada ee isha ama appendages ay. Sidoo kale, daawada aan la qaaday ee muddada postoperative, ama haddii ay jirto waa la dhimay wax soo saarka jeex.

Qadarka Qaadashada

In la abuuro maamul mydriasis ku filan oo ah hal dhibic ka mid ah 2.5% "Irifrin" ee koleyga ee conjunctival. Saamaynta ugu badnaan lagu arkay 15-30 daqiiqo ka dib waxana uu socdaa ilaa saddex saacadood. Haddii codsiga of xal 2.5% ah ku filnayn, carruurta ka weyn tahay 12 sano iyo bukaanada qaangaarka ah waxay dalban karaan xal 10% qiyaas isku mid ah.